TFF2 and infection: On the one hand, TFF2 is a brake for myeloid cells (e.g., inhibition of IL-6 and IL-12 release) so that, in particular, Th1 inflammation after a mucosal challenge (infection) is not overshooting (anti-inflammatory effect; Figure 3) [16,18,107,153].